Dr. Barbhaiya and her colleagues introduced their research, “Risk Factors for ‘Long Haul’ COVID-19 in Rheumatology Outpatients in New York City,” on the American College of Rheumatology (ACR) annual assembly.
For the research, Dr. Barbhaiya’s group emailed surveys to 7,505 women and men aged 18 years and older who had been handled at HSS for rheumatologic complaints between 2018 and 2020. Participants had been requested if that they had obtained a constructive take a look at for COVID-19 or if that they had been informed by a healthcare supplier that that they had contracted the an infection.
The researchers outlined long-haul COVID-19 infections as these with signs lasting one month or longer, whereas limited-duration instances had been thought of these with signs lasting lower than one month.
Among the two,572 people who accomplished the survey, practically 56% of sufferers who reported having contracted COVID-19 stated their signs lasted at the least one month. Only two sufferers within the research had a earlier prognosis of fibromyalgia a situation marked by fatigue, muscle aches and different signs which were related to long-haul COVID suggesting that overlap between the 2 problems is minimal.
“Our findings do not suggest that symptoms of fibromyalgia are being misinterpreted as long haul COVID in patients with rheumatic diseases, which is something that has been raised as a possibility,” stated Lisa A. Mandl, MD, MPH, a rheumatologist at HSS and senior writer of the brand new research.
HSS researchers plan to make use of the info as a part of a longitudinal evaluation of rheumatology sufferers with long-haul COVID to find out if the lingering signs of the an infection intervene with their rheumatologic circumstances. Ongoing surveillance of those sufferers will present vital perception on the long-term impression of COVID-19 in sufferers with rheumatic illness.
Source: Eurekalert
